AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.

Human Genome Sciences Inc.

Home » NASDAQ » Healthcare » Human Genome Sciences Inc.

Human Genome Sciences, Inc. operates as a biopharmaceutical company. Its principal products in development include BENLYSTA for systemic lupus erythematosus; and raxibacumab for inhalation anthrax.

  • Annual Reports
View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports